Morgan Stanley’s Adam Parker and team observe that biotech stocks now trade at the equal–or lower–valuations as US pharmaceutical companies. They consider the implications:
Kevin Hagen for The Wall Street Journal
US biotechnology stocks have markedly pulled back and now trade in line with US and European pharmaceutical companies on price-to-forward earnings....More>>>
On Wednesday, our Under the Radar Moversnewsletter suggested small cap educational children’s books stock Educational Development Corporation (NASDAQ: EDUC) as a short/bearish trade:
As for Educational Development, it too has dished out several key moving average crosses within the past few days… but not bullish ones – bearish ones. And, though its choppiness has become....More>>>
Quality tools can last you a lifetime… Even a basic set may be enough for you to do the job well, day in and day out. But you'll have limitations… A master craftsman can tell you that certain jobs require specialized tools. Having these tools at the right times – and knowing how to use them – can prove extremely valuable. Trading is no different…....More>>>
Famed investor and “Gloom, Boom & Doom Report” author Marc Faber is calling for a recession.
“I would put up interest rates,” Faber said during a conference hosted by CMC Market in Sydney, Australia, on Wednesday night. The U.S. Federal Reserve holds its next two-day meeting Nov. 1-2 — just six days ahead of the 2016 presidential election that has investors....More>>>